Academic Commons

Articles

A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency

White, Perrin; Ritzen, Martin; Oberfield, Sharon E.; Meyer-Bahlburg, Heino; Miller, Walter; Montori, Victor; Speiser, Phyllis; Azziz, Ricardo; Baskin, Laurence; Ghizzoni, Lucia; Hensle, Terry; Merke, Deborah

Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems important to develop the best practice guidelines for treating not only infants and children, but affected adults as well. This report gives a brief overview of the most recent expert opinion and clinical practice guidelines for CAH as formulated by The Endocrine Society Task Force.

Subjects

Files

  • thumnail for 1687-9856-2010-494173.xml 1687-9856-2010-494173.xml binary/octet-stream 39.1 KB Download File
  • thumnail for 1687-9856-2010-494173.pdf 1687-9856-2010-494173.pdf binary/octet-stream 471 KB Download File
  • thumnail for de40abb836577c966f3e07cb62dcff3b.zip de40abb836577c966f3e07cb62dcff3b.zip binary/octet-stream 463 KB Download File

Also Published In

Title
International Journal of Pediatric Endocrinology
DOI
https://doi.org/10.1155/2010/494173

More About This Work

Academic Units
Pediatrics
Publisher
BioMed Central
Published Here
September 8, 2014